Founded in 2007, the University of Washington Department of Global Health is committed to preparing the next generation of global health leaders through world-class education and training programs focused on research, evidence-based practice, and policy development. Our alumni work in more than 25 countries across five continents to improve health and eliminate health disparities around the world. We’re proud that our graduates go on to lead ministries of health, direct non-profit organizations, run research labs, develop medical innovations, hold public office, and more.
Each year, an open group from within the University of Washington Health Sciences selects a Common Book that serves as a platform for students from across health professions to learn together on topics of common importance. Throughout the school year students have the opportunity to participate in a series of lectures, interactive discussions, advocacy efforts, and seminars focused on the major topic(s) of the book.
Over the last two decades, Beatriz Thomé, MD, MPH, PhD, has worked as a pediatrician, research manager, university lecturer, and monitoring & evaluation specialist in countries as geographically disperse as Mozambique, Switzerland, and her native Brazil. When asked what’s the thread that ties together her wide-ranging career in public health, global health, and medicine, Thomé responds with a simple question: How can I contribute?
Founded in 1987 by Dr. Steve Gloyd, the University of Washington Department of Global Health Master of Public Health (MPH) program is one of the premier global health programs in the world, offering a unique combination of scholarship and activism.
For nearly seventeen months, the COVID-19 Literature Situation Report provided up-to-date information to the public health community about scientific evidence relevant to the COVID-19 pandemic. After more than 330 daily summaries, the project – a partnership between the Washington Department of Health (WA DOH) and University of Washington Department of Global Health (DGH) – ended on June 15, 2021.
Global health researchers at the University of Washington have received a $122 million grant from the Bill & Melinda Gates Foundation to test the effectiveness of the candidate drug islatravir, a once-a-month oral pill to prevent HIV.
The five-year grant will support the implementation of a Phase 3, randomized trial of islatravir, among women, in seven countries in sub-Saharan Africa. Islatravir is a nucleoside reverse transcriptase translocation inhibitor in development by Merck for the treatment and prevention of HIV-1 infection.
On Friday, June 11, the Department of Global Health (DGH) honored the Class of 2021 with a virtual graduation celebration. During the annual event, the 14th since the department was founded in 2007, speakers acknowledged the unique challenges and opportunities of the previous year, particularly for students entering the field of global health.
When Ana Gervassi went into panic mode forty-five minutes before the General Examinations for her doctoral degree, there was only one thing she could think to do. She went to the office of her faculty mentor, Lee Ann Campbell, a professor of global health and the director of the Interdisciplinary Pathobiology Program at the University of Washington.